For more than 50 years, MSU has been a leader in cancer research and treatment, from the discovery of cisplatin, the gold standard in cancer drugs, to building a dual-cyclotron radiopharmacy that produces radioactive isotopes used to treat cancer and help patients in Michigan and around the world. Now, the total-body PET/CT scanner, made possible through MSU's partnership with BAMF Health and in part by an honorary Spartans generosity, enables both research and clinical care and is the next step in MSU's cancer story.